Disclosure Panels Details Page
Neuroendocrine Tumors Panel - Disclosures as of 09/28/2011
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Al Benson III MD, FACCC, FACP, FASCO | Abbott Laboratories Amgen Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Eli Lilly and Company Genentech, Inc. General Electric Genomic Health, Inc. National Cancer Institute Onyx Pharmaceuticals, Inc. |
Abbott Laboratories Amgen Inc. AstraZeneca Pharmaceuticals LP Bayer HealthCare Eli Lilly and Company General Electric Genomic Health, Inc. National Cancer Institute Onyx Pharmaceuticals, Inc. |
None | None | ✔ |
| Emily Bergsland MD | Genentech, Inc. Novartis Pharmaceuticals Corporation sanofi-aventis U.S. |
Novartis Pharmaceuticals Corporation | None | None | ✔ |
| Jordan Berlin MD | Abbott Laboratories Amgen Inc. Bayer HealthCare Genentech, Inc. ImClone Systems Incorporated Pfizer |
Amgen Inc. AstraZeneca Pharmaceuticals LP Enzon Pharmaceuticals Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
None | None | - |
| Lawrence Blaszkowsky MD | Genentech, Inc. GSK |
None | None | None | ✔ |
| Michael Choti | None | Bayer HealthCare Bristol Myers Squibb Genentech, Inc. sanofi-aventis U.S. |
None | None | - |
| Orlo Clark MD | Xoma | Xoma | None | What Company? | ✔ |
| Gerard Doherty MD | None | Novartis Pharmaceuticals Corporation | None | None | - |
| Mary Dwyer MS | None | None | None | None | ✔ |
| Lyska Emerson MD | None | None | None | None | ✔ |
| Paul Engstrom MD, FACP | None | None | None | None | ✔ |
| Deborah Freedman-Cass PhD | None | None | None | None | ✔ |
| Lauren Gallagher | None | None | None | None | ✔ |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Martin Heslin MD | None | None | None | None | - |
| Fouad Kandeel MD, PhD | Molecular Insight Pharmaceuticals | Molecular Insights Pharmaceuticals | None | None | - |
| Margaret Kessinger MD | Pharmacyclics sanofi-aventis U.S. |
None | None | None | - |
| Matthew Kulke MD, MMSc | None | Ipsen Lexicon Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |
| Pamela Kunz MD | Genentech, Inc. | None | None | None | ✔ |
| Boris Kuvshinoff MD, MBA | None | None | None | None | ✔ |
| Joan McClure MS | None | None | None | None | ✔ |
| Jeffrey Moley MD | None | None | None | None | - |
| John A. Olson, Jr | None | None | None | None | - |
| Venu Pillarisetty MD | None | None | None | None | ✔ |
| Leonard Saltz MD | Amgen Inc. Bayer HealthCare Bristol Myers Squibb CureTech Ltd. Eli Lilly and Company Genentech, Inc. ImClone Systems Incorporated National Cancer Institute OSI Pharmaceuticals, Inc. Pfizer Inc. Roche Laboratories, Inc. Synta Pharmaceuticals Corp. Taiho Pharmaceuticals Co., Ltd. |
Abbott Laboratories Asuragen, Inc. CureTech Ltd. Genentech, Inc. Genomic Health, Inc. Genzyme Corporation Merck & Co., Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. YM BioScience Inc. |
None | None | ✔ |
| Manisha Shah MD | ImClone Systems Incorporated National Cancer Institute Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | None | None | ✔ |
| Jonathan Strosberg MD | Pfizer Inc. | Endo Pharmaceuticals | None | None | ✔ |
| Jean-Nicolas Vauthey MD | None | None | None | None | - |
| James Yao MD | Genentech, Inc. Ipsen Lexicon National Cancer Institute Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
National Cancer Institute Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | None | ✔ |